カテゴリー： 世界, 医療/バイオ, LP Information

世界のモンテルカストナトリウム製剤市場予測 2023年-2029年

【英語タイトル】Global Montelukast Sodium Preparations Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC00848）・商品コード：LP23DC00848
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：111
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥549,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥823,500見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,098,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のモンテルカストナトリウム製剤市場」は、過去の販売実績から2022年の世界のモンテルカストナトリウム製剤の総販売量を検討し、2023年から2029年の予測されるモンテルカストナトリウム製剤の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のモンテルカストナトリウム製剤の市場規模を掲載し、XXX百万米ドル規模の世界のモンテルカストナトリウム製剤市場の詳細な分析を提供します。本インサイトレポートは、世界のモンテルカストナトリウム製剤業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のモンテルカストナトリウム製剤市場における各社の独自のポジションをより深く理解するために、モンテルカストナトリウム製剤製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のモンテルカストナトリウム製剤市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。モンテルカストナトリウム製剤の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。モンテルカストナトリウム製剤の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。モンテルカストナトリウム製剤のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

モンテルカストナトリウム製剤の世界主要メーカーとしては、Morepen Laboratories、 Mylan、 Teva Pharmaceuticals、 Merck、 Sandoz、 Aurobindo Pharma、 Otsuka Pharmaceutical、 Yangtze River Pharmaceutical (Group) Co., Ltd.、 Beijing Winsunny Pharmaceutical Co., Ltd.、 Nanjing Hicin Pharmaceutical Co.,Ltd.、 Zhejiang NuoDe Pharmaceutical Co.， Ltd.、 Hefei Yingtai Pharmaceutical Co., Ltd.、 Lunan Better Pharmaceutical Co., Ltd.、 Qilu Pharmaceutical、 CSPC Pharmaceutical Group Limitedなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のモンテルカストナトリウム製剤市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではモンテルカストナトリウム製剤市場をセグメンテーションし、種類別 (チュアブル錠、レギュラー錠、粒剤)、用途別 (病院、診療所、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：チュアブル錠、レギュラー錠、粒剤

・用途別区分：病院、診療所、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界のモンテルカストナトリウム製剤市場の10年間の市場状況・展望は？
・世界および地域別に見たモンテルカストナトリウム製剤市場成長の要因は何か？
・モンテルカストナトリウム製剤の市場機会はエンドマーケットの規模によってどのように変化するのか？
・モンテルカストナトリウム製剤のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：モンテルカストナトリウム製剤の年間販売量2018-2029、地域別現状・将来分析
・モンテルカストナトリウム製剤の種類別セグメント：チュアブル錠、レギュラー錠、粒剤
・モンテルカストナトリウム製剤の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・モンテルカストナトリウム製剤の用途別セグメント：病院、診療所、その他
・モンテルカストナトリウム製剤の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のモンテルカストナトリウム製剤市場
・企業別のグローバルモンテルカストナトリウム製剤市場データ：2018-2023年の年間販売量、市場シェア
・企業別のモンテルカストナトリウム製剤の年間売上：2018-2023年の売上、市場シェア
・企業別のモンテルカストナトリウム製剤販売価格
・主要企業のモンテルカストナトリウム製剤生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

モンテルカストナトリウム製剤の地域別レビュー
・地域別のモンテルカストナトリウム製剤市場規模2018-2023：年間販売量、売上
・主要国別のモンテルカストナトリウム製剤市場規模2018-2023：年間販売量、売上
・南北アメリカのモンテルカストナトリウム製剤販売の成長
・アジア太平洋のモンテルカストナトリウム製剤販売の成長
・ヨーロッパのモンテルカストナトリウム製剤販売の成長
・中東・アフリカのモンテルカストナトリウム製剤販売の成長

南北アメリカ市場
・南北アメリカの国別のモンテルカストナトリウム製剤販売量、売上（2018-2023）
・南北アメリカのモンテルカストナトリウム製剤の種類別販売量
・南北アメリカのモンテルカストナトリウム製剤の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のモンテルカストナトリウム製剤販売量、売上（2018-2023）
・アジア太平洋のモンテルカストナトリウム製剤の種類別販売量
・アジア太平洋のモンテルカストナトリウム製剤の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のモンテルカストナトリウム製剤販売量、売上（2018-2023）
・ヨーロッパのモンテルカストナトリウム製剤の種類別販売量
・ヨーロッパのモンテルカストナトリウム製剤の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のモンテルカストナトリウム製剤販売量、売上（2018-2023）
・中東・アフリカのモンテルカストナトリウム製剤の種類別販売量
・中東・アフリカのモンテルカストナトリウム製剤の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・モンテルカストナトリウム製剤の製造コスト構造分析
・モンテルカストナトリウム製剤の製造プロセス分析
・モンテルカストナトリウム製剤の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・モンテルカストナトリウム製剤の主要なグローバル販売業者
・モンテルカストナトリウム製剤の主要なグローバル顧客

地域別のモンテルカストナトリウム製剤市場予測レビュー
・地域別のモンテルカストナトリウム製剤市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・モンテルカストナトリウム製剤の種類別市場規模予測
・モンテルカストナトリウム製剤の用途別市場規模予測

主要企業分析
Morepen Laboratories、 Mylan、 Teva Pharmaceuticals、 Merck、 Sandoz、 Aurobindo Pharma、 Otsuka Pharmaceutical、 Yangtze River Pharmaceutical (Group) Co., Ltd.、 Beijing Winsunny Pharmaceutical Co., Ltd.、 Nanjing Hicin Pharmaceutical Co.,Ltd.、 Zhejiang NuoDe Pharmaceutical Co.， Ltd.、 Hefei Yingtai Pharmaceutical Co., Ltd.、 Lunan Better Pharmaceutical Co., Ltd.、 Qilu Pharmaceutical、 CSPC Pharmaceutical Group Limited
・企業情報
・モンテルカストナトリウム製剤製品
・モンテルカストナトリウム製剤販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Montelukast Sodium Preparations market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Montelukast Sodium Preparations is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Montelukast Sodium Preparations is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Montelukast Sodium Preparations is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Montelukast Sodium Preparations players cover Morepen Laboratories, Mylan, Teva Pharmaceuticals, Merck, Sandoz, Aurobindo Pharma, Otsuka Pharmaceutical, Yangtze River Pharmaceutical (Group) Co., Ltd. and Beijing Winsunny Pharmaceutical Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)’ newest research report, the “Montelukast Sodium Preparations Industry Forecast” looks at past sales and reviews total world Montelukast Sodium Preparations sales in 2022, providing a comprehensive analysis by region and market sector of projected Montelukast Sodium Preparations sales for 2023 through 2029. With Montelukast Sodium Preparations sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Montelukast Sodium Preparations industry.
This Insight Report provides a comprehensive analysis of the global Montelukast Sodium Preparations landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Montelukast Sodium Preparations portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Montelukast Sodium Preparations market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Montelukast Sodium Preparations and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Montelukast Sodium Preparations.
This report presents a comprehensive overview, market shares, and growth opportunities of Montelukast Sodium Preparations market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Chewable Tablets
Regular Tablet
Particles
Segmentation by application
Hospital
Clinic
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Morepen Laboratories
Mylan
Teva Pharmaceuticals
Merck
Sandoz
Aurobindo Pharma
Otsuka Pharmaceutical
Yangtze River Pharmaceutical (Group) Co., Ltd.
Beijing Winsunny Pharmaceutical Co., Ltd.
Nanjing Hicin Pharmaceutical Co.,Ltd.
Zhejiang NuoDe Pharmaceutical Co.， Ltd.
Hefei Yingtai Pharmaceutical Co., Ltd.
Lunan Better Pharmaceutical Co., Ltd.
Qilu Pharmaceutical
CSPC Pharmaceutical Group Limited
Key Questions Addressed in this Report
What is the 10-year outlook for the global Montelukast Sodium Preparations market?
What factors are driving Montelukast Sodium Preparations market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Montelukast Sodium Preparations market opportunities vary by end market size?
How does Montelukast Sodium Preparations break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Montelukast Sodium Preparations Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Montelukast Sodium Preparations by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Montelukast Sodium Preparations by Country/Region, 2018, 2022 & 2029
2.2 Montelukast Sodium Preparations Segment by Type
2.2.1 Chewable Tablets
2.2.2 Regular Tablet
2.2.3 Particles
2.3 Montelukast Sodium Preparations Sales by Type
2.3.1 Global Montelukast Sodium Preparations Sales Market Share by Type (2018-2023)
2.3.2 Global Montelukast Sodium Preparations Revenue and Market Share by Type (2018-2023)
2.3.3 Global Montelukast Sodium Preparations Sale Price by Type (2018-2023)
2.4 Montelukast Sodium Preparations Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Montelukast Sodium Preparations Sales by Application
2.5.1 Global Montelukast Sodium Preparations Sale Market Share by Application (2018-2023)
2.5.2 Global Montelukast Sodium Preparations Revenue and Market Share by Application (2018-2023)
2.5.3 Global Montelukast Sodium Preparations Sale Price by Application (2018-2023)
3 Global Montelukast Sodium Preparations by Company
3.1 Global Montelukast Sodium Preparations Breakdown Data by Company
3.1.1 Global Montelukast Sodium Preparations Annual Sales by Company (2018-2023)
3.1.2 Global Montelukast Sodium Preparations Sales Market Share by Company (2018-2023)
3.2 Global Montelukast Sodium Preparations Annual Revenue by Company (2018-2023)
3.2.1 Global Montelukast Sodium Preparations Revenue by Company (2018-2023)
3.2.2 Global Montelukast Sodium Preparations Revenue Market Share by Company (2018-2023)
3.3 Global Montelukast Sodium Preparations Sale Price by Company
3.4 Key Manufacturers Montelukast Sodium Preparations Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Montelukast Sodium Preparations Product Location Distribution
3.4.2 Players Montelukast Sodium Preparations Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Montelukast Sodium Preparations by Geographic Region
4.1 World Historic Montelukast Sodium Preparations Market Size by Geographic Region (2018-2023)
4.1.1 Global Montelukast Sodium Preparations Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Montelukast Sodium Preparations Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Montelukast Sodium Preparations Market Size by Country/Region (2018-2023)
4.2.1 Global Montelukast Sodium Preparations Annual Sales by Country/Region (2018-2023)
4.2.2 Global Montelukast Sodium Preparations Annual Revenue by Country/Region (2018-2023)
4.3 Americas Montelukast Sodium Preparations Sales Growth
4.4 APAC Montelukast Sodium Preparations Sales Growth
4.5 Europe Montelukast Sodium Preparations Sales Growth
4.6 Middle East & Africa Montelukast Sodium Preparations Sales Growth
5 Americas
5.1 Americas Montelukast Sodium Preparations Sales by Country
5.1.1 Americas Montelukast Sodium Preparations Sales by Country (2018-2023)
5.1.2 Americas Montelukast Sodium Preparations Revenue by Country (2018-2023)
5.2 Americas Montelukast Sodium Preparations Sales by Type
5.3 Americas Montelukast Sodium Preparations Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Montelukast Sodium Preparations Sales by Region
6.1.1 APAC Montelukast Sodium Preparations Sales by Region (2018-2023)
6.1.2 APAC Montelukast Sodium Preparations Revenue by Region (2018-2023)
6.2 APAC Montelukast Sodium Preparations Sales by Type
6.3 APAC Montelukast Sodium Preparations Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Montelukast Sodium Preparations by Country
7.1.1 Europe Montelukast Sodium Preparations Sales by Country (2018-2023)
7.1.2 Europe Montelukast Sodium Preparations Revenue by Country (2018-2023)
7.2 Europe Montelukast Sodium Preparations Sales by Type
7.3 Europe Montelukast Sodium Preparations Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Montelukast Sodium Preparations by Country
8.1.1 Middle East & Africa Montelukast Sodium Preparations Sales by Country (2018-2023)
8.1.2 Middle East & Africa Montelukast Sodium Preparations Revenue by Country (2018-2023)
8.2 Middle East & Africa Montelukast Sodium Preparations Sales by Type
8.3 Middle East & Africa Montelukast Sodium Preparations Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Montelukast Sodium Preparations
10.3 Manufacturing Process Analysis of Montelukast Sodium Preparations
10.4 Industry Chain Structure of Montelukast Sodium Preparations
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Montelukast Sodium Preparations Distributors
11.3 Montelukast Sodium Preparations Customer
12 World Forecast Review for Montelukast Sodium Preparations by Geographic Region
12.1 Global Montelukast Sodium Preparations Market Size Forecast by Region
12.1.1 Global Montelukast Sodium Preparations Forecast by Region (2024-2029)
12.1.2 Global Montelukast Sodium Preparations Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Montelukast Sodium Preparations Forecast by Type
12.7 Global Montelukast Sodium Preparations Forecast by Application
13 Key Players Analysis
13.1 Morepen Laboratories
13.1.1 Morepen Laboratories Company Information
13.1.2 Morepen Laboratories Montelukast Sodium Preparations Product Portfolios and Specifications
13.1.3 Morepen Laboratories Montelukast Sodium Preparations Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Morepen Laboratories Main Business Overview
13.1.5 Morepen Laboratories Latest Developments
13.2 Mylan
13.2.1 Mylan Company Information
13.2.2 Mylan Montelukast Sodium Preparations Product Portfolios and Specifications
13.2.3 Mylan Montelukast Sodium Preparations Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Mylan Main Business Overview
13.2.5 Mylan Latest Developments
13.3 Teva Pharmaceuticals
13.3.1 Teva Pharmaceuticals Company Information
13.3.2 Teva Pharmaceuticals Montelukast Sodium Preparations Product Portfolios and Specifications
13.3.3 Teva Pharmaceuticals Montelukast Sodium Preparations Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Teva Pharmaceuticals Main Business Overview
13.3.5 Teva Pharmaceuticals Latest Developments
13.4 Merck
13.4.1 Merck Company Information
13.4.2 Merck Montelukast Sodium Preparations Product Portfolios and Specifications
13.4.3 Merck Montelukast Sodium Preparations Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Merck Main Business Overview
13.4.5 Merck Latest Developments
13.5 Sandoz
13.5.1 Sandoz Company Information
13.5.2 Sandoz Montelukast Sodium Preparations Product Portfolios and Specifications
13.5.3 Sandoz Montelukast Sodium Preparations Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Sandoz Main Business Overview
13.5.5 Sandoz Latest Developments
13.6 Aurobindo Pharma
13.6.1 Aurobindo Pharma Company Information
13.6.2 Aurobindo Pharma Montelukast Sodium Preparations Product Portfolios and Specifications
13.6.3 Aurobindo Pharma Montelukast Sodium Preparations Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Aurobindo Pharma Main Business Overview
13.6.5 Aurobindo Pharma Latest Developments
13.7 Otsuka Pharmaceutical
13.7.1 Otsuka Pharmaceutical Company Information
13.7.2 Otsuka Pharmaceutical Montelukast Sodium Preparations Product Portfolios and Specifications
13.7.3 Otsuka Pharmaceutical Montelukast Sodium Preparations Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Otsuka Pharmaceutical Main Business Overview
13.7.5 Otsuka Pharmaceutical Latest Developments
13.8 Yangtze River Pharmaceutical (Group) Co., Ltd.
13.8.1 Yangtze River Pharmaceutical (Group) Co., Ltd. Company Information
13.8.2 Yangtze River Pharmaceutical (Group) Co., Ltd. Montelukast Sodium Preparations Product Portfolios and Specifications
13.8.3 Yangtze River Pharmaceutical (Group) Co., Ltd. Montelukast Sodium Preparations Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Yangtze River Pharmaceutical (Group) Co., Ltd. Main Business Overview
13.8.5 Yangtze River Pharmaceutical (Group) Co., Ltd. Latest Developments
13.9 Beijing Winsunny Pharmaceutical Co., Ltd.
13.9.1 Beijing Winsunny Pharmaceutical Co., Ltd. Company Information
13.9.2 Beijing Winsunny Pharmaceutical Co., Ltd. Montelukast Sodium Preparations Product Portfolios and Specifications
13.9.3 Beijing Winsunny Pharmaceutical Co., Ltd. Montelukast Sodium Preparations Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Beijing Winsunny Pharmaceutical Co., Ltd. Main Business Overview
13.9.5 Beijing Winsunny Pharmaceutical Co., Ltd. Latest Developments
13.10 Nanjing Hicin Pharmaceutical Co.,Ltd.
13.10.1 Nanjing Hicin Pharmaceutical Co.,Ltd. Company Information
13.10.2 Nanjing Hicin Pharmaceutical Co.,Ltd. Montelukast Sodium Preparations Product Portfolios and Specifications
13.10.3 Nanjing Hicin Pharmaceutical Co.,Ltd. Montelukast Sodium Preparations Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Nanjing Hicin Pharmaceutical Co.,Ltd. Main Business Overview
13.10.5 Nanjing Hicin Pharmaceutical Co.,Ltd. Latest Developments
13.11 Zhejiang NuoDe Pharmaceutical Co.， Ltd.
13.11.1 Zhejiang NuoDe Pharmaceutical Co.， Ltd. Company Information
13.11.2 Zhejiang NuoDe Pharmaceutical Co.， Ltd. Montelukast Sodium Preparations Product Portfolios and Specifications
13.11.3 Zhejiang NuoDe Pharmaceutical Co.， Ltd. Montelukast Sodium Preparations Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Zhejiang NuoDe Pharmaceutical Co.， Ltd. Main Business Overview
13.11.5 Zhejiang NuoDe Pharmaceutical Co.， Ltd. Latest Developments
13.12 Hefei Yingtai Pharmaceutical Co., Ltd.
13.12.1 Hefei Yingtai Pharmaceutical Co., Ltd. Company Information
13.12.2 Hefei Yingtai Pharmaceutical Co., Ltd. Montelukast Sodium Preparations Product Portfolios and Specifications
13.12.3 Hefei Yingtai Pharmaceutical Co., Ltd. Montelukast Sodium Preparations Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Hefei Yingtai Pharmaceutical Co., Ltd. Main Business Overview
13.12.5 Hefei Yingtai Pharmaceutical Co., Ltd. Latest Developments
13.13 Lunan Better Pharmaceutical Co., Ltd.
13.13.1 Lunan Better Pharmaceutical Co., Ltd. Company Information
13.13.2 Lunan Better Pharmaceutical Co., Ltd. Montelukast Sodium Preparations Product Portfolios and Specifications
13.13.3 Lunan Better Pharmaceutical Co., Ltd. Montelukast Sodium Preparations Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Lunan Better Pharmaceutical Co., Ltd. Main Business Overview
13.13.5 Lunan Better Pharmaceutical Co., Ltd. Latest Developments
13.14 Qilu Pharmaceutical
13.14.1 Qilu Pharmaceutical Company Information
13.14.2 Qilu Pharmaceutical Montelukast Sodium Preparations Product Portfolios and Specifications
13.14.3 Qilu Pharmaceutical Montelukast Sodium Preparations Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Qilu Pharmaceutical Main Business Overview
13.14.5 Qilu Pharmaceutical Latest Developments
13.15 CSPC Pharmaceutical Group Limited
13.15.1 CSPC Pharmaceutical Group Limited Company Information
13.15.2 CSPC Pharmaceutical Group Limited Montelukast Sodium Preparations Product Portfolios and Specifications
13.15.3 CSPC Pharmaceutical Group Limited Montelukast Sodium Preparations Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 CSPC Pharmaceutical Group Limited Main Business Overview
13.15.5 CSPC Pharmaceutical Group Limited Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Montelukast Sodium Preparations Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Montelukast Sodium Preparations Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Chewable Tablets
Table 4. Major Players of Regular Tablet
Table 5. Major Players of Particles
Table 6. Global Montelukast Sodium Preparations Sales by Type (2018-2023) & (K Units)
Table 7. Global Montelukast Sodium Preparations Sales Market Share by Type (2018-2023)
Table 8. Global Montelukast Sodium Preparations Revenue by Type (2018-2023) & ($ million)
Table 9. Global Montelukast Sodium Preparations Revenue Market Share by Type (2018-2023)
Table 10. Global Montelukast Sodium Preparations Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Montelukast Sodium Preparations Sales by Application (2018-2023) & (K Units)
Table 12. Global Montelukast Sodium Preparations Sales Market Share by Application (2018-2023)
Table 13. Global Montelukast Sodium Preparations Revenue by Application (2018-2023)
Table 14. Global Montelukast Sodium Preparations Revenue Market Share by Application (2018-2023)
Table 15. Global Montelukast Sodium Preparations Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Montelukast Sodium Preparations Sales by Company (2018-2023) & (K Units)
Table 17. Global Montelukast Sodium Preparations Sales Market Share by Company (2018-2023)
Table 18. Global Montelukast Sodium Preparations Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Montelukast Sodium Preparations Revenue Market Share by Company (2018-2023)
Table 20. Global Montelukast Sodium Preparations Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Montelukast Sodium Preparations Producing Area Distribution and Sales Area
Table 22. Players Montelukast Sodium Preparations Products Offered
Table 23. Montelukast Sodium Preparations Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Montelukast Sodium Preparations Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Montelukast Sodium Preparations Sales Market Share Geographic Region (2018-2023)
Table 28. Global Montelukast Sodium Preparations Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Montelukast Sodium Preparations Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Montelukast Sodium Preparations Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Montelukast Sodium Preparations Sales Market Share by Country/Region (2018-2023)
Table 32. Global Montelukast Sodium Preparations Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Montelukast Sodium Preparations Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Montelukast Sodium Preparations Sales by Country (2018-2023) & (K Units)
Table 35. Americas Montelukast Sodium Preparations Sales Market Share by Country (2018-2023)
Table 36. Americas Montelukast Sodium Preparations Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Montelukast Sodium Preparations Revenue Market Share by Country (2018-2023)
Table 38. Americas Montelukast Sodium Preparations Sales by Type (2018-2023) & (K Units)
Table 39. Americas Montelukast Sodium Preparations Sales by Application (2018-2023) & (K Units)
Table 40. APAC Montelukast Sodium Preparations Sales by Region (2018-2023) & (K Units)
Table 41. APAC Montelukast Sodium Preparations Sales Market Share by Region (2018-2023)
Table 42. APAC Montelukast Sodium Preparations Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Montelukast Sodium Preparations Revenue Market Share by Region (2018-2023)
Table 44. APAC Montelukast Sodium Preparations Sales by Type (2018-2023) & (K Units)
Table 45. APAC Montelukast Sodium Preparations Sales by Application (2018-2023) & (K Units)
Table 46. Europe Montelukast Sodium Preparations Sales by Country (2018-2023) & (K Units)
Table 47. Europe Montelukast Sodium Preparations Sales Market Share by Country (2018-2023)
Table 48. Europe Montelukast Sodium Preparations Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Montelukast Sodium Preparations Revenue Market Share by Country (2018-2023)
Table 50. Europe Montelukast Sodium Preparations Sales by Type (2018-2023) & (K Units)
Table 51. Europe Montelukast Sodium Preparations Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Montelukast Sodium Preparations Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Montelukast Sodium Preparations Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Montelukast Sodium Preparations Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Montelukast Sodium Preparations Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Montelukast Sodium Preparations Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Montelukast Sodium Preparations Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Montelukast Sodium Preparations
Table 59. Key Market Challenges & Risks of Montelukast Sodium Preparations
Table 60. Key Industry Trends of Montelukast Sodium Preparations
Table 61. Montelukast Sodium Preparations Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Montelukast Sodium Preparations Distributors List
Table 64. Montelukast Sodium Preparations Customer List
Table 65. Global Montelukast Sodium Preparations Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Montelukast Sodium Preparations Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Montelukast Sodium Preparations Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Montelukast Sodium Preparations Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Montelukast Sodium Preparations Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Montelukast Sodium Preparations Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Montelukast Sodium Preparations Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Montelukast Sodium Preparations Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Montelukast Sodium Preparations Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Montelukast Sodium Preparations Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Montelukast Sodium Preparations Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Montelukast Sodium Preparations Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Montelukast Sodium Preparations Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Montelukast Sodium Preparations Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Morepen Laboratories Basic Information, Montelukast Sodium Preparations Manufacturing Base, Sales Area and Its Competitors
Table 80. Morepen Laboratories Montelukast Sodium Preparations Product Portfolios and Specifications
Table 81. Morepen Laboratories Montelukast Sodium Preparations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. Morepen Laboratories Main Business
Table 83. Morepen Laboratories Latest Developments
Table 84. Mylan Basic Information, Montelukast Sodium Preparations Manufacturing Base, Sales Area and Its Competitors
Table 85. Mylan Montelukast Sodium Preparations Product Portfolios and Specifications
Table 86. Mylan Montelukast Sodium Preparations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Mylan Main Business
Table 88. Mylan Latest Developments
Table 89. Teva Pharmaceuticals Basic Information, Montelukast Sodium Preparations Manufacturing Base, Sales Area and Its Competitors
Table 90. Teva Pharmaceuticals Montelukast Sodium Preparations Product Portfolios and Specifications
Table 91. Teva Pharmaceuticals Montelukast Sodium Preparations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. Teva Pharmaceuticals Main Business
Table 93. Teva Pharmaceuticals Latest Developments
Table 94. Merck Basic Information, Montelukast Sodium Preparations Manufacturing Base, Sales Area and Its Competitors
Table 95. Merck Montelukast Sodium Preparations Product Portfolios and Specifications
Table 96. Merck Montelukast Sodium Preparations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. Merck Main Business
Table 98. Merck Latest Developments
Table 99. Sandoz Basic Information, Montelukast Sodium Preparations Manufacturing Base, Sales Area and Its Competitors
Table 100. Sandoz Montelukast Sodium Preparations Product Portfolios and Specifications
Table 101. Sandoz Montelukast Sodium Preparations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. Sandoz Main Business
Table 103. Sandoz Latest Developments
Table 104. Aurobindo Pharma Basic Information, Montelukast Sodium Preparations Manufacturing Base, Sales Area and Its Competitors
Table 105. Aurobindo Pharma Montelukast Sodium Preparations Product Portfolios and Specifications
Table 106. Aurobindo Pharma Montelukast Sodium Preparations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Aurobindo Pharma Main Business
Table 108. Aurobindo Pharma Latest Developments
Table 109. Otsuka Pharmaceutical Basic Information, Montelukast Sodium Preparations Manufacturing Base, Sales Area and Its Competitors
Table 110. Otsuka Pharmaceutical Montelukast Sodium Preparations Product Portfolios and Specifications
Table 111. Otsuka Pharmaceutical Montelukast Sodium Preparations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Otsuka Pharmaceutical Main Business
Table 113. Otsuka Pharmaceutical Latest Developments
Table 114. Yangtze River Pharmaceutical (Group) Co., Ltd. Basic Information, Montelukast Sodium Preparations Manufacturing Base, Sales Area and Its Competitors
Table 115. Yangtze River Pharmaceutical (Group) Co., Ltd. Montelukast Sodium Preparations Product Portfolios and Specifications
Table 116. Yangtze River Pharmaceutical (Group) Co., Ltd. Montelukast Sodium Preparations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Yangtze River Pharmaceutical (Group) Co., Ltd. Main Business
Table 118. Yangtze River Pharmaceutical (Group) Co., Ltd. Latest Developments
Table 119. Beijing Winsunny Pharmaceutical Co., Ltd. Basic Information, Montelukast Sodium Preparations Manufacturing Base, Sales Area and Its Competitors
Table 120. Beijing Winsunny Pharmaceutical Co., Ltd. Montelukast Sodium Preparations Product Portfolios and Specifications
Table 121. Beijing Winsunny Pharmaceutical Co., Ltd. Montelukast Sodium Preparations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Beijing Winsunny Pharmaceutical Co., Ltd. Main Business
Table 123. Beijing Winsunny Pharmaceutical Co., Ltd. Latest Developments
Table 124. Nanjing Hicin Pharmaceutical Co.,Ltd. Basic Information, Montelukast Sodium Preparations Manufacturing Base, Sales Area and Its Competitors
Table 125. Nanjing Hicin Pharmaceutical Co.,Ltd. Montelukast Sodium Preparations Product Portfolios and Specifications
Table 126. Nanjing Hicin Pharmaceutical Co.,Ltd. Montelukast Sodium Preparations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. Nanjing Hicin Pharmaceutical Co.,Ltd. Main Business
Table 128. Nanjing Hicin Pharmaceutical Co.,Ltd. Latest Developments
Table 129. Zhejiang NuoDe Pharmaceutical Co.， Ltd. Basic Information, Montelukast Sodium Preparations Manufacturing Base, Sales Area and Its Competitors
Table 130. Zhejiang NuoDe Pharmaceutical Co.， Ltd. Montelukast Sodium Preparations Product Portfolios and Specifications
Table 131. Zhejiang NuoDe Pharmaceutical Co.， Ltd. Montelukast Sodium Preparations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. Zhejiang NuoDe Pharmaceutical Co.， Ltd. Main Business
Table 133. Zhejiang NuoDe Pharmaceutical Co.， Ltd. Latest Developments
Table 134. Hefei Yingtai Pharmaceutical Co., Ltd. Basic Information, Montelukast Sodium Preparations Manufacturing Base, Sales Area and Its Competitors
Table 135. Hefei Yingtai Pharmaceutical Co., Ltd. Montelukast Sodium Preparations Product Portfolios and Specifications
Table 136. Hefei Yingtai Pharmaceutical Co., Ltd. Montelukast Sodium Preparations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 137. Hefei Yingtai Pharmaceutical Co., Ltd. Main Business
Table 138. Hefei Yingtai Pharmaceutical Co., Ltd. Latest Developments
Table 139. Lunan Better Pharmaceutical Co., Ltd. Basic Information, Montelukast Sodium Preparations Manufacturing Base, Sales Area and Its Competitors
Table 140. Lunan Better Pharmaceutical Co., Ltd. Montelukast Sodium Preparations Product Portfolios and Specifications
Table 141. Lunan Better Pharmaceutical Co., Ltd. Montelukast Sodium Preparations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 142. Lunan Better Pharmaceutical Co., Ltd. Main Business
Table 143. Lunan Better Pharmaceutical Co., Ltd. Latest Developments
Table 144. Qilu Pharmaceutical Basic Information, Montelukast Sodium Preparations Manufacturing Base, Sales Area and Its Competitors
Table 145. Qilu Pharmaceutical Montelukast Sodium Preparations Product Portfolios and Specifications
Table 146. Qilu Pharmaceutical Montelukast Sodium Preparations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 147. Qilu Pharmaceutical Main Business
Table 148. Qilu Pharmaceutical Latest Developments
Table 149. CSPC Pharmaceutical Group Limited Basic Information, Montelukast Sodium Preparations Manufacturing Base, Sales Area and Its Competitors
Table 150. CSPC Pharmaceutical Group Limited Montelukast Sodium Preparations Product Portfolios and Specifications
Table 151. CSPC Pharmaceutical Group Limited Montelukast Sodium Preparations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 152. CSPC Pharmaceutical Group Limited Main Business
Table 153. CSPC Pharmaceutical Group Limited Latest Developments
List of Figures
Figure 1. Picture of Montelukast Sodium Preparations
Figure 2. Montelukast Sodium Preparations Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Montelukast Sodium Preparations Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Montelukast Sodium Preparations Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Montelukast Sodium Preparations Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Chewable Tablets
Figure 10. Product Picture of Regular Tablet
Figure 11. Product Picture of Particles
Figure 12. Global Montelukast Sodium Preparations Sales Market Share by Type in 2022
Figure 13. Global Montelukast Sodium Preparations Revenue Market Share by Type (2018-2023)
Figure 14. Montelukast Sodium Preparations Consumed in Hospital
Figure 15. Global Montelukast Sodium Preparations Market: Hospital (2018-2023) & (K Units)
Figure 16. Montelukast Sodium Preparations Consumed in Clinic
Figure 17. Global Montelukast Sodium Preparations Market: Clinic (2018-2023) & (K Units)
Figure 18. Montelukast Sodium Preparations Consumed in Other
Figure 19. Global Montelukast Sodium Preparations Market: Other (2018-2023) & (K Units)
Figure 20. Global Montelukast Sodium Preparations Sales Market Share by Application (2022)
Figure 21. Global Montelukast Sodium Preparations Revenue Market Share by Application in 2022
Figure 22. Montelukast Sodium Preparations Sales Market by Company in 2022 (K Units)
Figure 23. Global Montelukast Sodium Preparations Sales Market Share by Company in 2022
Figure 24. Montelukast Sodium Preparations Revenue Market by Company in 2022 ($ Million)
Figure 25. Global Montelukast Sodium Preparations Revenue Market Share by Company in 2022
Figure 26. Global Montelukast Sodium Preparations Sales Market Share by Geographic Region (2018-2023)
Figure 27. Global Montelukast Sodium Preparations Revenue Market Share by Geographic Region in 2022
Figure 28. Americas Montelukast Sodium Preparations Sales 2018-2023 (K Units)
Figure 29. Americas Montelukast Sodium Preparations Revenue 2018-2023 ($ Millions)
Figure 30. APAC Montelukast Sodium Preparations Sales 2018-2023 (K Units)
Figure 31. APAC Montelukast Sodium Preparations Revenue 2018-2023 ($ Millions)
Figure 32. Europe Montelukast Sodium Preparations Sales 2018-2023 (K Units)
Figure 33. Europe Montelukast Sodium Preparations Revenue 2018-2023 ($ Millions)
Figure 34. Middle East & Africa Montelukast Sodium Preparations Sales 2018-2023 (K Units)
Figure 35. Middle East & Africa Montelukast Sodium Preparations Revenue 2018-2023 ($ Millions)
Figure 36. Americas Montelukast Sodium Preparations Sales Market Share by Country in 2022
Figure 37. Americas Montelukast Sodium Preparations Revenue Market Share by Country in 2022
Figure 38. Americas Montelukast Sodium Preparations Sales Market Share by Type (2018-2023)
Figure 39. Americas Montelukast Sodium Preparations Sales Market Share by Application (2018-2023)
Figure 40. United States Montelukast Sodium Preparations Revenue Growth 2018-2023 ($ Millions)
Figure 41. Canada Montelukast Sodium Preparations Revenue Growth 2018-2023 ($ Millions)
Figure 42. Mexico Montelukast Sodium Preparations Revenue Growth 2018-2023 ($ Millions)
Figure 43. Brazil Montelukast Sodium Preparations Revenue Growth 2018-2023 ($ Millions)
Figure 44. APAC Montelukast Sodium Preparations Sales Market Share by Region in 2022
Figure 45. APAC Montelukast Sodium Preparations Revenue Market Share by Regions in 2022
Figure 46. APAC Montelukast Sodium Preparations Sales Market Share by Type (2018-2023)
Figure 47. APAC Montelukast Sodium Preparations Sales Market Share by Application (2018-2023)
Figure 48. China Montelukast Sodium Preparations Revenue Growth 2018-2023 ($ Millions)
Figure 49. Japan Montelukast Sodium Preparations Revenue Growth 2018-2023 ($ Millions)
Figure 50. South Korea Montelukast Sodium Preparations Revenue Growth 2018-2023 ($ Millions)
Figure 51. Southeast Asia Montelukast Sodium Preparations Revenue Growth 2018-2023 ($ Millions)
Figure 52. India Montelukast Sodium Preparations Revenue Growth 2018-2023 ($ Millions)
Figure 53. Australia Montelukast Sodium Preparations Revenue Growth 2018-2023 ($ Millions)
Figure 54. China Taiwan Montelukast Sodium Preparations Revenue Growth 2018-2023 ($ Millions)
Figure 55. Europe Montelukast Sodium Preparations Sales Market Share by Country in 2022
Figure 56. Europe Montelukast Sodium Preparations Revenue Market Share by Country in 2022
Figure 57. Europe Montelukast Sodium Preparations Sales Market Share by Type (2018-2023)
Figure 58. Europe Montelukast Sodium Preparations Sales Market Share by Application (2018-2023)
Figure 59. Germany Montelukast Sodium Preparations Revenue Growth 2018-2023 ($ Millions)
Figure 60. France Montelukast Sodium Preparations Revenue Growth 2018-2023 ($ Millions)
Figure 61. UK Montelukast Sodium Preparations Revenue Growth 2018-2023 ($ Millions)
Figure 62. Italy Montelukast Sodium Preparations Revenue Growth 2018-2023 ($ Millions)
Figure 63. Russia Montelukast Sodium Preparations Revenue Growth 2018-2023 ($ Millions)
Figure 64. Middle East & Africa Montelukast Sodium Preparations Sales Market Share by Country in 2022
Figure 65. Middle East & Africa Montelukast Sodium Preparations Revenue Market Share by Country in 2022
Figure 66. Middle East & Africa Montelukast Sodium Preparations Sales Market Share by Type (2018-2023)
Figure 67. Middle East & Africa Montelukast Sodium Preparations Sales Market Share by Application (2018-2023)
Figure 68. Egypt Montelukast Sodium Preparations Revenue Growth 2018-2023 ($ Millions)
Figure 69. South Africa Montelukast Sodium Preparations Revenue Growth 2018-2023 ($ Millions)
Figure 70. Israel Montelukast Sodium Preparations Revenue Growth 2018-2023 ($ Millions)
Figure 71. Turkey Montelukast Sodium Preparations Revenue Growth 2018-2023 ($ Millions)
Figure 72. GCC Country Montelukast Sodium Preparations Revenue Growth 2018-2023 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Montelukast Sodium Preparations in 2022
Figure 74. Manufacturing Process Analysis of Montelukast Sodium Preparations
Figure 75. Industry Chain Structure of Montelukast Sodium Preparations
Figure 76. Channels of Distribution
Figure 77. Global Montelukast Sodium Preparations Sales Market Forecast by Region (2024-2029)
Figure 78. Global Montelukast Sodium Preparations Revenue Market Share Forecast by Region (2024-2029)
Figure 79. Global Montelukast Sodium Preparations Sales Market Share Forecast by Type (2024-2029)
Figure 80. Global Montelukast Sodium Preparations Revenue Market Share Forecast by Type (2024-2029)
Figure 81. Global Montelukast Sodium Preparations Sales Market Share Forecast by Application (2024-2029)
Figure 82. Global Montelukast Sodium Preparations Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界のモンテルカストナトリウム製剤市場予測 2023年-2029年] (コード：LP23DC00848)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のモンテルカストナトリウム製剤市場予測 2023年-2029年]についてメールでお問い合わせ
カテゴリー： 世界, 医療/バイオ, LP Information

世界のモンテルカストナトリウム製剤市場予測 2023年-2029年

【英語タイトル】Global Montelukast Sodium Preparations Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC00848）・商品コード：LP23DC00848
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：111
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥549,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥823,500見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,098,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のモンテルカストナトリウム製剤市場」は、過去の販売実績から2022年の世界のモンテルカストナトリウム製剤の総販売量を検討し、2023年から2029年の予測されるモンテルカストナトリウム製剤の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のモンテルカストナトリウム製剤の市場規模を掲載し、XXX百万米ドル規模の世界のモンテルカストナトリウム製剤市場の詳細な分析を提供します。本インサイトレポートは、世界のモンテルカストナトリウム製剤業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のモンテルカストナトリウム製剤市場における各社の独自のポジションをより深く理解するために、モンテルカストナトリウム製剤製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のモンテルカストナトリウム製剤市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。モンテルカストナトリウム製剤の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。モンテルカストナトリウム製剤の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。モンテルカストナトリウム製剤のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

モンテルカストナトリウム製剤の世界主要メーカーとしては、Morepen Laboratories、 Mylan、 Teva Pharmaceuticals、 Merck、 Sandoz、 Aurobindo Pharma、 Otsuka Pharmaceutical、 Yangtze River Pharmaceutical (Group) Co., Ltd.、 Beijing Winsunny Pharmaceutical Co., Ltd.、 Nanjing Hicin Pharmaceutical Co.,Ltd.、 Zhejiang NuoDe Pharmaceutical Co.， Ltd.、 Hefei Yingtai Pharmaceutical Co., Ltd.、 Lunan Better Pharmaceutical Co., Ltd.、 Qilu Pharmaceutical、 CSPC Pharmaceutical Group Limitedなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のモンテルカストナトリウム製剤市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではモンテルカストナトリウム製剤市場をセグメンテーションし、種類別 (チュアブル錠、レギュラー錠、粒剤)、用途別 (病院、診療所、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：チュアブル錠、レギュラー錠、粒剤

・用途別区分：病院、診療所、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界のモンテルカストナトリウム製剤市場の10年間の市場状況・展望は？
・世界および地域別に見たモンテルカストナトリウム製剤市場成長の要因は何か？
・モンテルカストナトリウム製剤の市場機会はエンドマーケットの規模によってどのように変化するのか？
・モンテルカストナトリウム製剤のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：モンテルカストナトリウム製剤の年間販売量2018-2029、地域別現状・将来分析
・モンテルカストナトリウム製剤の種類別セグメント：チュアブル錠、レギュラー錠、粒剤
・モンテルカストナトリウム製剤の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・モンテルカストナトリウム製剤の用途別セグメント：病院、診療所、その他
・モンテルカストナトリウム製剤の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のモンテルカストナトリウム製剤市場
・企業別のグローバルモンテルカストナトリウム製剤市場データ：2018-2023年の年間販売量、市場シェア
・企業別のモンテルカストナトリウム製剤の年間売上：2018-2023年の売上、市場シェア
・企業別のモンテルカストナトリウム製剤販売価格
・主要企業のモンテルカストナトリウム製剤生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

モンテルカストナトリウム製剤の地域別レビュー
・地域別のモンテルカストナトリウム製剤市場規模2018-2023：年間販売量、売上
・主要国別のモンテルカストナトリウム製剤市場規模2018-2023：年間販売量、売上
・南北アメリカのモンテルカストナトリウム製剤販売の成長
・アジア太平洋のモンテルカストナトリウム製剤販売の成長
・ヨーロッパのモンテルカストナトリウム製剤販売の成長
・中東・アフリカのモンテルカストナトリウム製剤販売の成長

南北アメリカ市場
・南北アメリカの国別のモンテルカストナトリウム製剤販売量、売上（2018-2023）
・南北アメリカのモンテルカストナトリウム製剤の種類別販売量
・南北アメリカのモンテルカストナトリウム製剤の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のモンテルカストナトリウム製剤販売量、売上（2018-2023）
・アジア太平洋のモンテルカストナトリウム製剤の種類別販売量
・アジア太平洋のモンテルカストナトリウム製剤の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のモンテルカストナトリウム製剤販売量、売上（2018-2023）
・ヨーロッパのモンテルカストナトリウム製剤の種類別販売量
・ヨーロッパのモンテルカストナトリウム製剤の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のモンテルカストナトリウム製剤販売量、売上（2018-2023）
・中東・アフリカのモンテルカストナトリウム製剤の種類別販売量
・中東・アフリカのモンテルカストナトリウム製剤の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・モンテルカストナトリウム製剤の製造コスト構造分析
・モンテルカストナトリウム製剤の製造プロセス分析
・モンテルカストナトリウム製剤の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・モンテルカストナトリウム製剤の主要なグローバル販売業者
・モンテルカストナトリウム製剤の主要なグローバル顧客

地域別のモンテルカストナトリウム製剤市場予測レビュー
・地域別のモンテルカストナトリウム製剤市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・モンテルカストナトリウム製剤の種類別市場規模予測
・モンテルカストナトリウム製剤の用途別市場規模予測

主要企業分析
Morepen Laboratories、 Mylan、 Teva Pharmaceuticals、 Merck、 Sandoz、 Aurobindo Pharma、 Otsuka Pharmaceutical、 Yangtze River Pharmaceutical (Group) Co., Ltd.、 Beijing Winsunny Pharmaceutical Co., Ltd.、 Nanjing Hicin Pharmaceutical Co.,Ltd.、 Zhejiang NuoDe Pharmaceutical Co.， Ltd.、 Hefei Yingtai Pharmaceutical Co., Ltd.、 Lunan Better Pharmaceutical Co., Ltd.、 Qilu Pharmaceutical、 CSPC Pharmaceutical Group Limited
・企業情報
・モンテルカストナトリウム製剤製品
・モンテルカストナトリウム製剤販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Montelukast Sodium Preparations market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Montelukast Sodium Preparations is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Montelukast Sodium Preparations is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Montelukast Sodium Preparations is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Montelukast Sodium Preparations players cover Morepen Laboratories, Mylan, Teva Pharmaceuticals, Merck, Sandoz, Aurobindo Pharma, Otsuka Pharmaceutical, Yangtze River Pharmaceutical (Group) Co., Ltd. and Beijing Winsunny Pharmaceutical Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)’ newest research report, the “Montelukast Sodium Preparations Industry Forecast” looks at past sales and reviews total world Montelukast Sodium Preparations sales in 2022, providing a comprehensive analysis by region and market sector of projected Montelukast Sodium Preparations sales for 2023 through 2029. With Montelukast Sodium Preparations sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Montelukast Sodium Preparations industry.
This Insight Report provides a comprehensive analysis of the global Montelukast Sodium Preparations landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Montelukast Sodium Preparations portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Montelukast Sodium Preparations market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Montelukast Sodium Preparations and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Montelukast Sodium Preparations.
This report presents a comprehensive overview, market shares, and growth opportunities of Montelukast Sodium Preparations market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Chewable Tablets
Regular Tablet
Particles
Segmentation by application
Hospital
Clinic
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Morepen Laboratories
Mylan
Teva Pharmaceuticals
Merck
Sandoz
Aurobindo Pharma
Otsuka Pharmaceutical
Yangtze River Pharmaceutical (Group) Co., Ltd.
Beijing Winsunny Pharmaceutical Co., Ltd.
Nanjing Hicin Pharmaceutical Co.,Ltd.
Zhejiang NuoDe Pharmaceutical Co.， Ltd.
Hefei Yingtai Pharmaceutical Co., Ltd.
Lunan Better Pharmaceutical Co., Ltd.
Qilu Pharmaceutical
CSPC Pharmaceutical Group Limited
Key Questions Addressed in this Report
What is the 10-year outlook for the global Montelukast Sodium Preparations market?
What factors are driving Montelukast Sodium Preparations market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Montelukast Sodium Preparations market opportunities vary by end market size?
How does Montelukast Sodium Preparations break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Montelukast Sodium Preparations Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Montelukast Sodium Preparations by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Montelukast Sodium Preparations by Country/Region, 2018, 2022 & 2029
2.2 Montelukast Sodium Preparations Segment by Type
2.2.1 Chewable Tablets
2.2.2 Regular Tablet
2.2.3 Particles
2.3 Montelukast Sodium Preparations Sales by Type
2.3.1 Global Montelukast Sodium Preparations Sales Market Share by Type (2018-2023)
2.3.2 Global Montelukast Sodium Preparations Revenue and Market Share by Type (2018-2023)
2.3.3 Global Montelukast Sodium Preparations Sale Price by Type (2018-2023)
2.4 Montelukast Sodium Preparations Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Montelukast Sodium Preparations Sales by Application
2.5.1 Global Montelukast Sodium Preparations Sale Market Share by Application (2018-2023)
2.5.2 Global Montelukast Sodium Preparations Revenue and Market Share by Application (2018-2023)
2.5.3 Global Montelukast Sodium Preparations Sale Price by Application (2018-2023)
3 Global Montelukast Sodium Preparations by Company
3.1 Global Montelukast Sodium Preparations Breakdown Data by Company
3.1.1 Global Montelukast Sodium Preparations Annual Sales by Company (2018-2023)
3.1.2 Global Montelukast Sodium Preparations Sales Market Share by Company (2018-2023)
3.2 Global Montelukast Sodium Preparations Annual Revenue by Company (2018-2023)
3.2.1 Global Montelukast Sodium Preparations Revenue by Company (2018-2023)
3.2.2 Global Montelukast Sodium Preparations Revenue Market Share by Company (2018-2023)
3.3 Global Montelukast Sodium Preparations Sale Price by Company
3.4 Key Manufacturers Montelukast Sodium Preparations Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Montelukast Sodium Preparations Product Location Distribution
3.4.2 Players Montelukast Sodium Preparations Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Montelukast Sodium Preparations by Geographic Region
4.1 World Historic Montelukast Sodium Preparations Market Size by Geographic Region (2018-2023)
4.1.1 Global Montelukast Sodium Preparations Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Montelukast Sodium Preparations Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Montelukast Sodium Preparations Market Size by Country/Region (2018-2023)
4.2.1 Global Montelukast Sodium Preparations Annual Sales by Country/Region (2018-2023)
4.2.2 Global Montelukast Sodium Preparations Annual Revenue by Country/Region (2018-2023)
4.3 Americas Montelukast Sodium Preparations Sales Growth
4.4 APAC Montelukast Sodium Preparations Sales Growth
4.5 Europe Montelukast Sodium Preparations Sales Growth
4.6 Middle East & Africa Montelukast Sodium Preparations Sales Growth
5 Americas
5.1 Americas Montelukast Sodium Preparations Sales by Country
5.1.1 Americas Montelukast Sodium Preparations Sales by Country (2018-2023)
5.1.2 Americas Montelukast Sodium Preparations Revenue by Country (2018-2023)
5.2 Americas Montelukast Sodium Preparations Sales by Type
5.3 Americas Montelukast Sodium Preparations Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Montelukast Sodium Preparations Sales by Region
6.1.1 APAC Montelukast Sodium Preparations Sales by Region (2018-2023)
6.1.2 APAC Montelukast Sodium Preparations Revenue by Region (2018-2023)
6.2 APAC Montelukast Sodium Preparations Sales by Type
6.3 APAC Montelukast Sodium Preparations Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Montelukast Sodium Preparations by Country
7.1.1 Europe Montelukast Sodium Preparations Sales by Country (2018-2023)
7.1.2 Europe Montelukast Sodium Preparations Revenue by Country (2018-2023)
7.2 Europe Montelukast Sodium Preparations Sales by Type
7.3 Europe Montelukast Sodium Preparations Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Montelukast Sodium Preparations by Country
8.1.1 Middle East & Africa Montelukast Sodium Preparations Sales by Country (2018-2023)
8.1.2 Middle East & Africa Montelukast Sodium Preparations Revenue by Country (2018-2023)
8.2 Middle East & Africa Montelukast Sodium Preparations Sales by Type
8.3 Middle East & Africa Montelukast Sodium Preparations Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Montelukast Sodium Preparations
10.3 Manufacturing Process Analysis of Montelukast Sodium Preparations
10.4 Industry Chain Structure of Montelukast Sodium Preparations
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Montelukast Sodium Preparations Distributors
11.3 Montelukast Sodium Preparations Customer
12 World Forecast Review for Montelukast Sodium Preparations by Geographic Region
12.1 Global Montelukast Sodium Preparations Market Size Forecast by Region
12.1.1 Global Montelukast Sodium Preparations Forecast by Region (2024-2029)
12.1.2 Global Montelukast Sodium Preparations Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Montelukast Sodium Preparations Forecast by Type
12.7 Global Montelukast Sodium Preparations Forecast by Application
13 Key Players Analysis
13.1 Morepen Laboratories
13.1.1 Morepen Laboratories Company Information
13.1.2 Morepen Laboratories Montelukast Sodium Preparations Product Portfolios and Specifications
13.1.3 Morepen Laboratories Montelukast Sodium Preparations Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Morepen Laboratories Main Business Overview
13.1.5 Morepen Laboratories Latest Developments
13.2 Mylan
13.2.1 Mylan Company Information
13.2.2 Mylan Montelukast Sodium Preparations Product Portfolios and Specifications
13.2.3 Mylan Montelukast Sodium Preparations Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Mylan Main Business Overview
13.2.5 Mylan Latest Developments
13.3 Teva Pharmaceuticals
13.3.1 Teva Pharmaceuticals Company Information
13.3.2 Teva Pharmaceuticals Montelukast Sodium Preparations Product Portfolios and Specifications
13.3.3 Teva Pharmaceuticals Montelukast Sodium Preparations Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Teva Pharmaceuticals Main Business Overview
13.3.5 Teva Pharmaceuticals Latest Developments
13.4 Merck
13.4.1 Merck Company Information
13.4.2 Merck Montelukast Sodium Preparations Product Portfolios and Specifications
13.4.3 Merck Montelukast Sodium Preparations Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Merck Main Business Overview
13.4.5 Merck Latest Developments
13.5 Sandoz
13.5.1 Sandoz Company Information
13.5.2 Sandoz Montelukast Sodium Preparations Product Portfolios and Specifications
13.5.3 Sandoz Montelukast Sodium Preparations Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Sandoz Main Business Overview
13.5.5 Sandoz Latest Developments
13.6 Aurobindo Pharma
13.6.1 Aurobindo Pharma Company Information
13.6.2 Aurobindo Pharma Montelukast Sodium Preparations Product Portfolios and Specifications
13.6.3 Aurobindo Pharma Montelukast Sodium Preparations Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Aurobindo Pharma Main Business Overview
13.6.5 Aurobindo Pharma Latest Developments
13.7 Otsuka Pharmaceutical
13.7.1 Otsuka Pharmaceutical Company Information
13.7.2 Otsuka Pharmaceutical Montelukast Sodium Preparations Product Portfolios and Specifications
13.7.3 Otsuka Pharmaceutical Montelukast Sodium Preparations Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Otsuka Pharmaceutical Main Business Overview
13.7.5 Otsuka Pharmaceutical Latest Developments
13.8 Yangtze River Pharmaceutical (Group) Co., Ltd.
13.8.1 Yangtze River Pharmaceutical (Group) Co., Ltd. Company Information
13.8.2 Yangtze River Pharmaceutical (Group) Co., Ltd. Montelukast Sodium Preparations Product Portfolios and Specifications
13.8.3 Yangtze River Pharmaceutical (Group) Co., Ltd. Montelukast Sodium Preparations Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Yangtze River Pharmaceutical (Group) Co., Ltd. Main Business Overview
13.8.5 Yangtze River Pharmaceutical (Group) Co., Ltd. Latest Developments
13.9 Beijing Winsunny Pharmaceutical Co., Ltd.
13.9.1 Beijing Winsunny Pharmaceutical Co., Ltd. Company Information
13.9.2 Beijing Winsunny Pharmaceutical Co., Ltd. Montelukast Sodium Preparations Product Portfolios and Specifications
13.9.3 Beijing Winsunny Pharmaceutical Co., Ltd. Montelukast Sodium Preparations Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Beijing Winsunny Pharmaceutical Co., Ltd. Main Business Overview
13.9.5 Beijing Winsunny Pharmaceutical Co., Ltd. Latest Developments
13.10 Nanjing Hicin Pharmaceutical Co.,Ltd.
13.10.1 Nanjing Hicin Pharmaceutical Co.,Ltd. Company Information
13.10.2 Nanjing Hicin Pharmaceutical Co.,Ltd. Montelukast Sodium Preparations Product Portfolios and Specifications
13.10.3 Nanjing Hicin Pharmaceutical Co.,Ltd. Montelukast Sodium Preparations Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Nanjing Hicin Pharmaceutical Co.,Ltd. Main Business Overview
13.10.5 Nanjing Hicin Pharmaceutical Co.,Ltd. Latest Developments
13.11 Zhejiang NuoDe Pharmaceutical Co.， Ltd.
13.11.1 Zhejiang NuoDe Pharmaceutical Co.， Ltd. Company Information
13.11.2 Zhejiang NuoDe Pharmaceutical Co.， Ltd. Montelukast Sodium Preparations Product Portfolios and Specifications
13.11.3 Zhejiang NuoDe Pharmaceutical Co.， Ltd. Montelukast Sodium Preparations Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Zhejiang NuoDe Pharmaceutical Co.， Ltd. Main Business Overview
13.11.5 Zhejiang NuoDe Pharmaceutical Co.， Ltd. Latest Developments
13.12 Hefei Yingtai Pharmaceutical Co., Ltd.
13.12.1 Hefei Yingtai Pharmaceutical Co., Ltd. Company Information
13.12.2 Hefei Yingtai Pharmaceutical Co., Ltd. Montelukast Sodium Preparations Product Portfolios and Specifications
13.12.3 Hefei Yingtai Pharmaceutical Co., Ltd. Montelukast Sodium Preparations Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Hefei Yingtai Pharmaceutical Co., Ltd. Main Business Overview
13.12.5 Hefei Yingtai Pharmaceutical Co., Ltd. Latest Developments
13.13 Lunan Better Pharmaceutical Co., Ltd.
13.13.1 Lunan Better Pharmaceutical Co., Ltd. Company Information
13.13.2 Lunan Better Pharmaceutical Co., Ltd. Montelukast Sodium Preparations Product Portfolios and Specifications
13.13.3 Lunan Better Pharmaceutical Co., Ltd. Montelukast Sodium Preparations Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Lunan Better Pharmaceutical Co., Ltd. Main Business Overview
13.13.5 Lunan Better Pharmaceutical Co., Ltd. Latest Developments
13.14 Qilu Pharmaceutical
13.14.1 Qilu Pharmaceutical Company Information
13.14.2 Qilu Pharmaceutical Montelukast Sodium Preparations Product Portfolios and Specifications
13.14.3 Qilu Pharmaceutical Montelukast Sodium Preparations Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Qilu Pharmaceutical Main Business Overview
13.14.5 Qilu Pharmaceutical Latest Developments
13.15 CSPC Pharmaceutical Group Limited
13.15.1 CSPC Pharmaceutical Group Limited Company Information
13.15.2 CSPC Pharmaceutical Group Limited Montelukast Sodium Preparations Product Portfolios and Specifications
13.15.3 CSPC Pharmaceutical Group Limited Montelukast Sodium Preparations Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 CSPC Pharmaceutical Group Limited Main Business Overview
13.15.5 CSPC Pharmaceutical Group Limited Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Montelukast Sodium Preparations Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Montelukast Sodium Preparations Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Chewable Tablets
Table 4. Major Players of Regular Tablet
Table 5. Major Players of Particles
Table 6. Global Montelukast Sodium Preparations Sales by Type (2018-2023) & (K Units)
Table 7. Global Montelukast Sodium Preparations Sales Market Share by Type (2018-2023)
Table 8. Global Montelukast Sodium Preparations Revenue by Type (2018-2023) & ($ million)
Table 9. Global Montelukast Sodium Preparations Revenue Market Share by Type (2018-2023)
Table 10. Global Montelukast Sodium Preparations Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Montelukast Sodium Preparations Sales by Application (2018-2023) & (K Units)
Table 12. Global Montelukast Sodium Preparations Sales Market Share by Application (2018-2023)
Table 13. Global Montelukast Sodium Preparations Revenue by Application (2018-2023)
Table 14. Global Montelukast Sodium Preparations Revenue Market Share by Application (2018-2023)
Table 15. Global Montelukast Sodium Preparations Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Montelukast Sodium Preparations Sales by Company (2018-2023) & (K Units)
Table 17. Global Montelukast Sodium Preparations Sales Market Share by Company (2018-2023)
Table 18. Global Montelukast Sodium Preparations Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Montelukast Sodium Preparations Revenue Market Share by Company (2018-2023)
Table 20. Global Montelukast Sodium Preparations Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Montelukast Sodium Preparations Producing Area Distribution and Sales Area
Table 22. Players Montelukast Sodium Preparations Products Offered
Table 23. Montelukast Sodium Preparations Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Montelukast Sodium Preparations Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Montelukast Sodium Preparations Sales Market Share Geographic Region (2018-2023)
Table 28. Global Montelukast Sodium Preparations Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Montelukast Sodium Preparations Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Montelukast Sodium Preparations Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Montelukast Sodium Preparations Sales Market Share by Country/Region (2018-2023)
Table 32. Global Montelukast Sodium Preparations Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Montelukast Sodium Preparations Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Montelukast Sodium Preparations Sales by Country (2018-2023) & (K Units)
Table 35. Americas Montelukast Sodium Preparations Sales Market Share by Country (2018-2023)
Table 36. Americas Montelukast Sodium Preparations Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Montelukast Sodium Preparations Revenue Market Share by Country (2018-2023)
Table 38. Americas Montelukast Sodium Preparations Sales by Type (2018-2023) & (K Units)
Table 39. Americas Montelukast Sodium Preparations Sales by Application (2018-2023) & (K Units)
Table 40. APAC Montelukast Sodium Preparations Sales by Region (2018-2023) & (K Units)
Table 41. APAC Montelukast Sodium Preparations Sales Market Share by Region (2018-2023)
Table 42. APAC Montelukast Sodium Preparations Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Montelukast Sodium Preparations Revenue Market Share by Region (2018-2023)
Table 44. APAC Montelukast Sodium Preparations Sales by Type (2018-2023) & (K Units)
Table 45. APAC Montelukast Sodium Preparations Sales by Application (2018-2023) & (K Units)
Table 46. Europe Montelukast Sodium Preparations Sales by Country (2018-2023) & (K Units)
Table 47. Europe Montelukast Sodium Preparations Sales Market Share by Country (2018-2023)
Table 48. Europe Montelukast Sodium Preparations Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Montelukast Sodium Preparations Revenue Market Share by Country (2018-2023)
Table 50. Europe Montelukast Sodium Preparations Sales by Type (2018-2023) & (K Units)
Table 51. Europe Montelukast Sodium Preparations Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Montelukast Sodium Preparations Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Montelukast Sodium Preparations Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Montelukast Sodium Preparations Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Montelukast Sodium Preparations Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Montelukast Sodium Preparations Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Montelukast Sodium Preparations Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Montelukast Sodium Preparations
Table 59. Key Market Challenges & Risks of Montelukast Sodium Preparations
Table 60. Key Industry Trends of Montelukast Sodium Preparations
Table 61. Montelukast Sodium Preparations Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Montelukast Sodium Preparations Distributors List
Table 64. Montelukast Sodium Preparations Customer List
Table 65. Global Montelukast Sodium Preparations Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Montelukast Sodium Preparations Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Montelukast Sodium Preparations Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Montelukast Sodium Preparations Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Montelukast Sodium Preparations Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Montelukast Sodium Preparations Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Montelukast Sodium Preparations Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Montelukast Sodium Preparations Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Montelukast Sodium Preparations Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Montelukast Sodium Preparations Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Montelukast Sodium Preparations Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Montelukast Sodium Preparations Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Montelukast Sodium Preparations Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Montelukast Sodium Preparations Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Morepen Laboratories Basic Information, Montelukast Sodium Preparations Manufacturing Base, Sales Area and Its Competitors
Table 80. Morepen Laboratories Montelukast Sodium Preparations Product Portfolios and Specifications
Table 81. Morepen Laboratories Montelukast Sodium Preparations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. Morepen Laboratories Main Business
Table 83. Morepen Laboratories Latest Developments
Table 84. Mylan Basic Information, Montelukast Sodium Preparations Manufacturing Base, Sales Area and Its Competitors
Table 85. Mylan Montelukast Sodium Preparations Product Portfolios and Specifications
Table 86. Mylan Montelukast Sodium Preparations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Mylan Main Business
Table 88. Mylan Latest Developments
Table 89. Teva Pharmaceuticals Basic Information, Montelukast Sodium Preparations Manufacturing Base, Sales Area and Its Competitors
Table 90. Teva Pharmaceuticals Montelukast Sodium Preparations Product Portfolios and Specifications
Table 91. Teva Pharmaceuticals Montelukast Sodium Preparations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. Teva Pharmaceuticals Main Business
Table 93. Teva Pharmaceuticals Latest Developments
Table 94. Merck Basic Information, Montelukast Sodium Preparations Manufacturing Base, Sales Area and Its Competitors
Table 95. Merck Montelukast Sodium Preparations Product Portfolios and Specifications
Table 96. Merck Montelukast Sodium Preparations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. Merck Main Business
Table 98. Merck Latest Developments
Table 99. Sandoz Basic Information, Montelukast Sodium Preparations Manufacturing Base, Sales Area and Its Competitors
Table 100. Sandoz Montelukast Sodium Preparations Product Portfolios and Specifications
Table 101. Sandoz Montelukast Sodium Preparations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. Sandoz Main Business
Table 103. Sandoz Latest Developments
Table 104. Aurobindo Pharma Basic Information, Montelukast Sodium Preparations Manufacturing Base, Sales Area and Its Competitors
Table 105. Aurobindo Pharma Montelukast Sodium Preparations Product Portfolios and Specifications
Table 106. Aurobindo Pharma Montelukast Sodium Preparations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Aurobindo Pharma Main Business
Table 108. Aurobindo Pharma Latest Developments
Table 109. Otsuka Pharmaceutical Basic Information, Montelukast Sodium Preparations Manufacturing Base, Sales Area and Its Competitors
Table 110. Otsuka Pharmaceutical Montelukast Sodium Preparations Product Portfolios and Specifications
Table 111. Otsuka Pharmaceutical Montelukast Sodium Preparations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Otsuka Pharmaceutical Main Business
Table 113. Otsuka Pharmaceutical Latest Developments
Table 114. Yangtze River Pharmaceutical (Group) Co., Ltd. Basic Information, Montelukast Sodium Preparations Manufacturing Base, Sales Area and Its Competitors
Table 115. Yangtze River Pharmaceutical (Group) Co., Ltd. Montelukast Sodium Preparations Product Portfolios and Specifications
Table 116. Yangtze River Pharmaceutical (Group) Co., Ltd. Montelukast Sodium Preparations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Yangtze River Pharmaceutical (Group) Co., Ltd. Main Business
Table 118. Yangtze River Pharmaceutical (Group) Co., Ltd. Latest Developments
Table 119. Beijing Winsunny Pharmaceutical Co., Ltd. Basic Information, Montelukast Sodium Preparations Manufacturing Base, Sales Area and Its Competitors
Table 120. Beijing Winsunny Pharmaceutical Co., Ltd. Montelukast Sodium Preparations Product Portfolios and Specifications
Table 121. Beijing Winsunny Pharmaceutical Co., Ltd. Montelukast Sodium Preparations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Beijing Winsunny Pharmaceutical Co., Ltd. Main Business
Table 123. Beijing Winsunny Pharmaceutical Co., Ltd. Latest Developments
Table 124. Nanjing Hicin Pharmaceutical Co.,Ltd. Basic Information, Montelukast Sodium Preparations Manufacturing Base, Sales Area and Its Competitors
Table 125. Nanjing Hicin Pharmaceutical Co.,Ltd. Montelukast Sodium Preparations Product Portfolios and Specifications
Table 126. Nanjing Hicin Pharmaceutical Co.,Ltd. Montelukast Sodium Preparations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. Nanjing Hicin Pharmaceutical Co.,Ltd. Main Business
Table 128. Nanjing Hicin Pharmaceutical Co.,Ltd. Latest Developments
Table 129. Zhejiang NuoDe Pharmaceutical Co.， Ltd. Basic Information, Montelukast Sodium Preparations Manufacturing Base, Sales Area and Its Competitors
Table 130. Zhejiang NuoDe Pharmaceutical Co.， Ltd. Montelukast Sodium Preparations Product Portfolios and Specifications
Table 131. Zhejiang NuoDe Pharmaceutical Co.， Ltd. Montelukast Sodium Preparations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. Zhejiang NuoDe Pharmaceutical Co.， Ltd. Main Business
Table 133. Zhejiang NuoDe Pharmaceutical Co.， Ltd. Latest Developments
Table 134. Hefei Yingtai Pharmaceutical Co., Ltd. Basic Information, Montelukast Sodium Preparations Manufacturing Base, Sales Area and Its Competitors
Table 135. Hefei Yingtai Pharmaceutical Co., Ltd. Montelukast Sodium Preparations Product Portfolios and Specifications
Table 136. Hefei Yingtai Pharmaceutical Co., Ltd. Montelukast Sodium Preparations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 137. Hefei Yingtai Pharmaceutical Co., Ltd. Main Business
Table 138. Hefei Yingtai Pharmaceutical Co., Ltd. Latest Developments
Table 139. Lunan Better Pharmaceutical Co., Ltd. Basic Information, Montelukast Sodium Preparations Manufacturing Base, Sales Area and Its Competitors
Table 140. Lunan Better Pharmaceutical Co., Ltd. Montelukast Sodium Preparations Product Portfolios and Specifications
Table 141. Lunan Better Pharmaceutical Co., Ltd. Montelukast Sodium Preparations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 142. Lunan Better Pharmaceutical Co., Ltd. Main Business
Table 143. Lunan Better Pharmaceutical Co., Ltd. Latest Developments
Table 144. Qilu Pharmaceutical Basic Information, Montelukast Sodium Preparations Manufacturing Base, Sales Area and Its Competitors
Table 145. Qilu Pharmaceutical Montelukast Sodium Preparations Product Portfolios and Specifications
Table 146. Qilu Pharmaceutical Montelukast Sodium Preparations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 147. Qilu Pharmaceutical Main Business
Table 148. Qilu Pharmaceutical Latest Developments
Table 149. CSPC Pharmaceutical Group Limited Basic Information, Montelukast Sodium Preparations Manufacturing Base, Sales Area and Its Competitors
Table 150. CSPC Pharmaceutical Group Limited Montelukast Sodium Preparations Product Portfolios and Specifications
Table 151. CSPC Pharmaceutical Group Limited Montelukast Sodium Preparations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 152. CSPC Pharmaceutical Group Limited Main Business
Table 153. CSPC Pharmaceutical Group Limited Latest Developments
List of Figures
Figure 1. Picture of Montelukast Sodium Preparations
Figure 2. Montelukast Sodium Preparations Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Montelukast Sodium Preparations Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Montelukast Sodium Preparations Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Montelukast Sodium Preparations Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Chewable Tablets
Figure 10. Product Picture of Regular Tablet
Figure 11. Product Picture of Particles
Figure 12. Global Montelukast Sodium Preparations Sales Market Share by Type in 2022
Figure 13. Global Montelukast Sodium Preparations Revenue Market Share by Type (2018-2023)
Figure 14. Montelukast Sodium Preparations Consumed in Hospital
Figure 15. Global Montelukast Sodium Preparations Market: Hospital (2018-2023) & (K Units)
Figure 16. Montelukast Sodium Preparations Consumed in Clinic
Figure 17. Global Montelukast Sodium Preparations Market: Clinic (2018-2023) & (K Units)
Figure 18. Montelukast Sodium Preparations Consumed in Other
Figure 19. Global Montelukast Sodium Preparations Market: Other (2018-2023) & (K Units)
Figure 20. Global Montelukast Sodium Preparations Sales Market Share by Application (2022)
Figure 21. Global Montelukast Sodium Preparations Revenue Market Share by Application in 2022
Figure 22. Montelukast Sodium Preparations Sales Market by Company in 2022 (K Units)
Figure 23. Global Montelukast Sodium Preparations Sales Market Share by Company in 2022
Figure 24. Montelukast Sodium Preparations Revenue Market by Company in 2022 ($ Million)
Figure 25. Global Montelukast Sodium Preparations Revenue Market Share by Company in 2022
Figure 26. Global Montelukast Sodium Preparations Sales Market Share by Geographic Region (2018-2023)
Figure 27. Global Montelukast Sodium Preparations Revenue Market Share by Geographic Region in 2022
Figure 28. Americas Montelukast Sodium Preparations Sales 2018-2023 (K Units)
Figure 29. Americas Montelukast Sodium Preparations Revenue 2018-2023 ($ Millions)
Figure 30. APAC Montelukast Sodium Preparations Sales 2018-2023 (K Units)
Figure 31. APAC Montelukast Sodium Preparations Revenue 2018-2023 ($ Millions)
Figure 32. Europe Montelukast Sodium Preparations Sales 2018-2023 (K Units)
Figure 33. Europe Montelukast Sodium Preparations Revenue 2018-2023 ($ Millions)
Figure 34. Middle East & Africa Montelukast Sodium Preparations Sales 2018-2023 (K Units)
Figure 35. Middle East & Africa Montelukast Sodium Preparations Revenue 2018-2023 ($ Millions)
Figure 36. Americas Montelukast Sodium Preparations Sales Market Share by Country in 2022
Figure 37. Americas Montelukast Sodium Preparations Revenue Market Share by Country in 2022
Figure 38. Americas Montelukast Sodium Preparations Sales Market Share by Type (2018-2023)
Figure 39. Americas Montelukast Sodium Preparations Sales Market Share by Application (2018-2023)
Figure 40. United States Montelukast Sodium Preparations Revenue Growth 2018-2023 ($ Millions)
Figure 41. Canada Montelukast Sodium Preparations Revenue Growth 2018-2023 ($ Millions)
Figure 42. Mexico Montelukast Sodium Preparations Revenue Growth 2018-2023 ($ Millions)
Figure 43. Brazil Montelukast Sodium Preparations Revenue Growth 2018-2023 ($ Millions)
Figure 44. APAC Montelukast Sodium Preparations Sales Market Share by Region in 2022
Figure 45. APAC Montelukast Sodium Preparations Revenue Market Share by Regions in 2022
Figure 46. APAC Montelukast Sodium Preparations Sales Market Share by Type (2018-2023)
Figure 47. APAC Montelukast Sodium Preparations Sales Market Share by Application (2018-2023)
Figure 48. China Montelukast Sodium Preparations Revenue Growth 2018-2023 ($ Millions)
Figure 49. Japan Montelukast Sodium Preparations Revenue Growth 2018-2023 ($ Millions)
Figure 50. South Korea Montelukast Sodium Preparations Revenue Growth 2018-2023 ($ Millions)
Figure 51. Southeast Asia Montelukast Sodium Preparations Revenue Growth 2018-2023 ($ Millions)
Figure 52. India Montelukast Sodium Preparations Revenue Growth 2018-2023 ($ Millions)
Figure 53. Australia Montelukast Sodium Preparations Revenue Growth 2018-2023 ($ Millions)
Figure 54. China Taiwan Montelukast Sodium Preparations Revenue Growth 2018-2023 ($ Millions)
Figure 55. Europe Montelukast Sodium Preparations Sales Market Share by Country in 2022
Figure 56. Europe Montelukast Sodium Preparations Revenue Market Share by Country in 2022
Figure 57. Europe Montelukast Sodium Preparations Sales Market Share by Type (2018-2023)
Figure 58. Europe Montelukast Sodium Preparations Sales Market Share by Application (2018-2023)
Figure 59. Germany Montelukast Sodium Preparations Revenue Growth 2018-2023 ($ Millions)
Figure 60. France Montelukast Sodium Preparations Revenue Growth 2018-2023 ($ Millions)
Figure 61. UK Montelukast Sodium Preparations Revenue Growth 2018-2023 ($ Millions)
Figure 62. Italy Montelukast Sodium Preparations Revenue Growth 2018-2023 ($ Millions)
Figure 63. Russia Montelukast Sodium Preparations Revenue Growth 2018-2023 ($ Millions)
Figure 64. Middle East & Africa Montelukast Sodium Preparations Sales Market Share by Country in 2022
Figure 65. Middle East & Africa Montelukast Sodium Preparations Revenue Market Share by Country in 2022
Figure 66. Middle East & Africa Montelukast Sodium Preparations Sales Market Share by Type (2018-2023)
Figure 67. Middle East & Africa Montelukast Sodium Preparations Sales Market Share by Application (2018-2023)
Figure 68. Egypt Montelukast Sodium Preparations Revenue Growth 2018-2023 ($ Millions)
Figure 69. South Africa Montelukast Sodium Preparations Revenue Growth 2018-2023 ($ Millions)
Figure 70. Israel Montelukast Sodium Preparations Revenue Growth 2018-2023 ($ Millions)
Figure 71. Turkey Montelukast Sodium Preparations Revenue Growth 2018-2023 ($ Millions)
Figure 72. GCC Country Montelukast Sodium Preparations Revenue Growth 2018-2023 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Montelukast Sodium Preparations in 2022
Figure 74. Manufacturing Process Analysis of Montelukast Sodium Preparations
Figure 75. Industry Chain Structure of Montelukast Sodium Preparations
Figure 76. Channels of Distribution
Figure 77. Global Montelukast Sodium Preparations Sales Market Forecast by Region (2024-2029)
Figure 78. Global Montelukast Sodium Preparations Revenue Market Share Forecast by Region (2024-2029)
Figure 79. Global Montelukast Sodium Preparations Sales Market Share Forecast by Type (2024-2029)
Figure 80. Global Montelukast Sodium Preparations Revenue Market Share Forecast by Type (2024-2029)
Figure 81. Global Montelukast Sodium Preparations Sales Market Share Forecast by Application (2024-2029)
Figure 82. Global Montelukast Sodium Preparations Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界のモンテルカストナトリウム製剤市場予測 2023年-2029年] (コード：LP23DC00848)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のモンテルカストナトリウム製剤市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のモンテルカストナトリウム製剤市場予測 2023年-2029年
  • 世界のメチルプレドニゾロン製剤市場予測 2023年-2029年
  • 世界のラベプラゾールナトリウム腸溶コーティングカプセル市場予測 2023年-2029年
  • 世界のアンブロキソール塩酸塩塩化ナトリウム注射液市場予測 2023年-2029年
  • 世界のバルプロ酸ナトリウムSR錠剤市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆